Solace Pharmaceuticals Company Profile

07:31 EDT 26th April 2015 | BioPortfolio

Solace Pharmaceuticals discovers and develops innovative treatments for pain. Solace's research and development programs are focused on exploiting novel biological understanding of disease targets that play a role in the pathogenesis of pain and that have disease-modifying potential in two key areas: modulating the activity of glial cells and intervening in the tetrohydrobiopterin (BH4) pathway. SLC022, the company's lead drug candidate, is in phase II clinical development in patients with post-herpetic neuralgia (PHN). Solace's research and development are supported by a strong and expanding intellectual property portfolio. For more information, please visit the company's website at www.solacepharma.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

Valeant trumps Endo with $10.96 billion bid for Salix Pharma

Valeant Pharmaceuticals International Inc increased its offer for Salix Pharmaceuticals Inc to $10.96 billion in cash on Monday, eclipsing Endo International Plc , the only other bidder. Salix would b...

A Second Randomized Controlled Trial (RCT) of the Vesair™ Bladder Control System Meets Study Endpoints with Statistical Significance.

Solace Therapeutics, Inc., today announced that data from a multicenter 63 patient randomized controlled trial has met study endpoints with statistical significance. Data from thi...

Immunocore gains MedCity head

Dr Eliot Forster, the man responsible for growing the life science cluster, MedCity, in London and the South East since it was established last year, is to become CEO of Immunocore, a biotech company ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Solace Stress Urinary inContinence Control Efficacy and Safety Study

The SUCCESS Trial is designed to determine whether the Solace Bladder Control System is safe and effective for the treatment of Stress Urinary Incontinence (SUI) in adult females.

Companies [5 Associated Companies listed on BioPortfolio]

Solace Therapeutics, Inc.

Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office based treatments for common bladder disorders, such as stress urinary incontinence (SUI), ov...

Solace Therapeutics Inc.

Solace Therapeutics is dedicated to developing innovative, non-surgical and clinically effective devices that address unmet needs in lower urinary tract symptoms (LUTS). Our initi...

Solace Lifesciences

Solace Lifesciences, the creators of NuCalm, is a pioneer in the fields of applied neuropsychobiology and bioinformatics. Founded in 2002, the company is dedicated to improving th...

Solace Pharmaceuticals

Solace Pharmaceuticals discovers and develops innovative treatments for pain. Solace's research and development programs are focused on exploiting novel biological understanding of disease targets th...

Armed Forces Foundation

The Armed Forces Foundation is a non-profit organization dedicated to providing solace to members of the Armed Forces community during their time of greatest need. For more information, visit www.arme...

More Information about "Solace Pharmaceuticals" on BioPortfolio

We have published hundreds of Solace Pharmaceuticals news stories on BioPortfolio along with dozens of Solace Pharmaceuticals Clinical Trials and PubMed Articles about Solace Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Solace Pharmaceuticals Companies in our database. You can also find out about relevant Solace Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Anesthesiology
Latest News Clinical Trials Research Drugs Reports Corporate
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Pain
Latest News Clinical Trials Research Drugs Reports Corporate
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record